Tenecteplase in Wake-up Ischaemic Stroke Trial "TWIST"

Recruiting

Phase 3 Results N/A

Summary of Purpose

Stroke is a leading causes of death and disability. At least 20% of strokes occur during sleep, so- called 'wake up stroke'. Thrombolysis with the clot-busting drug alteplase is effective for acute ischaemic stroke, provided that it is given within 4.5 hours of symptom onset. Patients with wake-up stroke are currently ineligible for clot-busting therapy. Previous studies indicate that many wake-up strokes occur...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 July 2017.

12 Jun 2017 6 Jun 2017 31 Dec 2019 31 Dec 2022 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts